BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 17003493)

  • 1. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
    Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
    Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing fibrovascular septa from vasculogenic mimicry patterns.
    Lin AY; Maniotis AJ; Valyi-Nagy K; Majumdar D; Setty S; Kadkol S; Leach L; Pe'er J; Folberg R
    Arch Pathol Lab Med; 2005 Jul; 129(7):884-92. PubMed ID: 15974811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of human uveal melanoma invasion and metastasis.
    Seftor EA; Meltzer PS; Kirschmann DA; Pe'er J; Maniotis AJ; Trent JM; Folberg R; Hendrix MJ
    Clin Exp Metastasis; 2002; 19(3):233-46. PubMed ID: 12067204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
    Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the behavior of uveal melanoma in the liver.
    Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment.
    Seftor EA; Meltzer PS; Kirschmann DA; Margaryan NV; Seftor RE; Hendrix MJ
    J Cell Mol Med; 2006; 10(1):174-96. PubMed ID: 16563230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculogenic mimicry and tumor angiogenesis.
    Folberg R; Hendrix MJ; Maniotis AJ
    Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
    Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ
    Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis.
    Stålhammar G; See TRO; Phillips SS; Grossniklaus HE
    Mol Vis; 2019; 25():502-516. PubMed ID: 31588174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
    Manarang JC; Otteson DC; McDermott AM
    Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasculogenic mimicry.
    Folberg R; Maniotis AJ
    APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
    Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
    Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
    Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
    Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
    Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
    Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
    Hendrix MJ; Seftor EA; Hess AR; Seftor RE
    Nat Rev Cancer; 2003 Jun; 3(6):411-21. PubMed ID: 12778131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.
    Zhang R; Chen X; Chen S; Tang J; Chen F; Lin Y; Reinach PS; Yan X; Tu L; Duan H; Qu J; Hou Q
    Cell Oncol (Dordr); 2022 Aug; 45(4):557-572. PubMed ID: 35716258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.